Corcoran Nicholas 4
4 · TransMedics Group, Inc. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Corcoran Nicholas
See remarks
Transactions
- Exercise/Conversion
Common Stock
2024-08-27$83.14/sh+2,190$182,077→ 31,105 total - Exercise/Conversion
Common Stock
2024-08-27$66.10/sh+7,810$516,241→ 28,915 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-27−7,810→ 11,922 totalExercise: $66.10Exp: 2033-02-20→ Common Stock (7,810 underlying) - Sale
Common Stock
2024-08-27$176.02/sh−10,000$1,760,200→ 21,105 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-27−2,190→ 15,442 totalExercise: $83.14Exp: 2034-02-23→ Common Stock (2,190 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $176.00 to $176.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.
- [F3]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.